Submissions for variant NM_006939.4(SOS2):c.599A>G (p.Tyr200Cys)

gnomAD frequency: 0.00016  dbSNP: rs148595463

Total submissions: 5

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Labcorp Genetics (formerly Invitae), Labcorp	RCV000945752	SCV001091804	likely benign	Noonan syndrome 9	2025-01-20	criteria provided, single submitter	clinical testing
Ambry Genetics	RCV002354841	SCV002655739	likely benign	Cardiovascular phenotype	2021-08-05	criteria provided, single submitter	clinical testing	This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Genome-Nilou Lab	RCV000945752	SCV002763126	likely benign	Noonan syndrome 9		criteria provided, single submitter	clinical testing
Revvity Omics, Revvity	RCV000945752	SCV003822101	uncertain significance	Noonan syndrome 9	2020-05-12	criteria provided, single submitter	clinical testing
PreventionGenetics, part of Exact Sciences	RCV003925854	SCV004745343	likely benign	SOS2-related disorder	2022-07-27	no assertion criteria provided	clinical testing	This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).